Table 2.
Analysis of breast cancer specific survival and time to relapse in the whole group of patients by Cox regression
|
Variable |
n |
Breast cancer specific survival |
Time to relapse |
||
|---|---|---|---|---|---|
| HR (95% CI) | p-value | HR (95%CI) | p-value | ||
| Age |
|
|
|
|
|
| <=55 |
172 |
|
|
|
|
| >55 |
183 |
0.948 (0.638-1.408) |
0.791 |
0.993 (0.698-1.413) |
0.969 |
| GASC1 status |
|
|
|
|
|
| positive |
157 |
|
|
|
|
| negative |
198 |
2.040 (1.345-3.092) |
0.001 |
1.766 (1.230-2.535) |
0.002 |
| Nodal status |
|
|
|
|
|
| negative |
193 |
|
|
|
|
| positive |
162 |
3.177 (1.768-5.710) |
0.000 |
2.835 (1.702-4.723) |
0.000 |
| Tumor size |
|
|
|
|
|
| T1 |
168 |
|
|
|
|
| T2+T3+T4 |
187 |
0.621 (0.356-1.080) |
0.092 |
0.707 (0.431-1.161) |
0.171 |
| Clinical stage |
|
|
|
|
|
| I |
120 |
|
|
|
|
| II+III+IV |
230 |
1.107 (0.456-2.687) |
0.823 |
1.092 (0.511-2.335) |
0.820 |
| unknown | 5 | ||||
n – number of cases, HR – hazard ratio.